The US drug regulator is conducting audits at Sun Pharma's Halol facility in Gujarat. Sun had recalled multiple products made in this facility. Could this spell further trouble for Sun Pharma? Pharma Asia News India bureau chief Vikas Dandekar spoke with CNBC-TV18‘s Senthil Chengalvarayan and Sonia Shenoy to discuss the development.
first published: Sep 11, 2014 06:48 pm
A collection of the most-viewed Moneycontrol videos.
Live: Will Nifty continue its rangebound move this week? | Opening Bell
The Lawyer Renting in a 120-year-old building in South Mumbai | The Tenant
Nifty On Track To End Week Above 25,500 As Bank & Metal Stocks Lead Rebound| Closing Bell Live
Can Nifty Stage A Friday Fightback After Hitting 3-Week Low? Pine Labs IPO Opens | Opening Bell Live
